Intestinal anti-inflammatory activity of apigenin K in two rat colitis models induced by trinitrobenzenesulfonic acid and dextran sulphate sodium

British Journal of Nutrition

Volumn 113, Issue 4, 2015, Pages 618-626

  Mascaraque, Cristina ^a   González, Raquel ^a   Suárez, María Dolores ^a   Zarzuelo, Antonio ^a   De Medina, Fermín Sánchez ^a   Martínez Augustin, Olga ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Flavonoids; Inflammatory bowel disease; Nutraceuticals

Indexed keywords

ALKALINE PHOSPHATASE; APIGENIN; APIGENIN K; BUDESONIDE; CXCL2 CHEMOKINE; DEXTRAN SULFATE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MYELOPEROXIDASE; TRANSFORMING GROWTH FACTOR BETA; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; BIOLOGICAL MARKER; GASTROINTESTINAL AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOCHEMISTRY; COLITIS; COLON; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENZYME ACTIVITY; FEMALE; INFLAMMATORY BOWEL DISEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MOTIF; RAT; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE MODEL; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; ORGAN SIZE; PATHOLOGY; PILOT STUDY; RANDOMIZATION; SOLUBILITY; WISTAR RAT;

RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APIGENIN; BIOLOGICAL MARKERS; COLITIS; COLON; DEXTRAN SULFATE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL AGENTS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; ORGAN SIZE; PILOT PROJECTS; RANDOM ALLOCATION; RATS, WISTAR; SOLUBILITY; TRINITROBENZENESULFONIC ACID;

EID: 84923612968     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514004292     Document Type: Article

References (45)

1. González R, Ballester I, López-Posadas R, et al. (2011) Effects of flavonoids and other polyphenols on inflammation. Crit Rev Food Sci Nutr 51, 331-362
2. Lopez-Posadas R, Ballester I, Mascaraque C, et al. (2010) Flavonoids exert distinct modulatory actions on cyclooxygenase 2 and NF-kB in an intestinal epithelial cell line (IEC18). Br J Pharmacol 160, 1714-1726
3. Galvez J, Sanchez De Medina F, Jiménez J, et al. (2001) Effects of flavonoids on gastrointestinal disorders. In Studies in Natural Products Chemistry Bioactive Natural Products (Part F), pp. 565-604 [R Atta Ur, editor]. Amsterdam: Elsevier Science Publishers
4. Wang Y, Xu YS, Yin LH, et al. (2013) Synergistic anti-glioma effect of hydroxygenkwanin and apigenin in vitro. Chem Biol Interact 206, 346-355
5. Mafuvadze B, Cook M, Xu Z, et al. (2013) Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-Accelerated 7, 12-dimethylbenz( a)anthracene-induced breast cancer model. Nutr Cancer 65, 1184-1191
6. Shao H, Jing K, Mahmoud E, et al. (2013) Apigenin sensitizes colon cancer cells to antitumor activity of ABT-263. Mol Cancer Ther 12, 2640-2650
7. Shukla S, Bhaskaran N, Babcook MA, et al. (2014) Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway. Carcinogenesis 35, 452-460
8. Wang YC & Huang KM (2013) In vitro anti-inflammatory effect of apigenin in the Helicobacter pylori-infected gastric adenocarcinoma cells. Food Chem Toxicol 53, 376-383
9. Hoensch H & Oertel R (2012) Anti-inflammatory effects of tea-flavonoids. Dtsch Med Wochenschr 137, 2738-2740
10. Man MQ, Hupe M, Sun R, et al. (2012) Topical apigenin alleviates cutaneous inflammation in murine models. Evid Based Complement Alternat Med 2012, 912028
11. Ganjare AB, Nirmal SA & Patil AN (2011) Use of apigenin from Cordia dichotoma in the treatment of colitis. Fitoterapia 82, 1052-1056
12. Abraham C & Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361, 2066-2078
13. Gassull MA (2004) Review Article: the role of nutrition in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther 20, Suppl. 4, 79-83
14. Kawai Y, Nishikawa T, Shiba Y, et al. (2008) Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-Atherosclerotic mechanism of dietary flavonoids. J Biol Chem 283, 9424-9434
15. Wirtz S, Neufert C, Weigmann B, et al. (2007) Chemically induced mouse models of intestinal inflammation. Nat Protoc 2, 541-546
16. Morris GP, Beck PL, Herridge MS, et al. (1989) Hapteninduced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96, 795-803
17. Cooper HS, Murthy SN, Shah RS, et al. (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69, 238-249
18. Daddaoua A, Puerta V, Zarzuelo A, et al. (2005) Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis. J Nutr 135, 1164-1170
19. Lopez-Posadas R, Requena P, Gonzalez R, et al. (2010) Bovine glycomacropeptide has intestinal antiinflammatory effects in rats with dextran sulfate-induced colitis. J Nutr 140, 2014-2019
20. Ito R, Kita M, Shin-Ya M, et al. (2008) Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun 377, 12-16
21. Sanchez De Medina F, Martinez-Augustin O, Gonzalez R, et al. (2004) Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease. Biochem Pharmacol 68, 2317-2326
22. Kerr TA, Ciorba MA, Matsumoto H, et al. (2012) Dextran sodium sulfate inhibition of real-time polymerase chain reaction amplification: a poly-A purification solution. Inflamm Bowel Dis 18, 344-348
23. Lopez-Posadas R, Gonzalez R, Ballester I, et al. (2011) Tissue-nonspecific alkaline phosphatase is activated in enterocytes by oxidative stress via changes in glycosylation. Inflamm Bowel Dis 17, 543-556
24. Park Y, Jin HS, Lopez J, et al. (2013) TSC1 regulates the balance between effector and regulatory T cells. J Clin Invest 123, 5165-5178
25. Li L, Liu S, Xu Y, et al. (2013) Human umbilical cord-derived mesenchymal stem cells downregulate inflammatory responses by shifting the Treg/Th17 profile in experimental colitis. Pharmacology 92, 257-264
26. Furusawa Y, Obata Y, Fukuda S, et al. (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446-450
27. Nicholas C, Batra S, Vargo MA, et al. (2007) Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kB through the suppression of p65 phosphorylation. J Immunol 179, 7121-7127
28. Comalada M, Ballester I, Bailon E, et al. (2006) Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-Activity relationship. Biochem Pharmacol 72, 1010-1021
29. Park J, Kim SH & Kim TS (2006) Inhibition of interleukin-4 production in activated T cells via down-regulation of NF-AT DNA binding activity by apigenin, a flavonoid present in dietary plants. Immunol Lett 103, 108-114
30. Yin Y, Gong FY, Wu XX, et al. (2008) Anti-inflammatory and immunosuppressive effect of flavones isolated from Artemisia vestita. J Ethnopharmacol 120, 1-6
31. Liang ZD, Zeng YY, Huang XY, et al. (2008) Effect of apigenin on proliferation, cell cycle and apoptosis of mouse T cells in vitro. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 24, 337-340
32. López-Posadas R, Ballester I, Abadía A, et al. (2008) Effect of flavonoids on rat splenocytes, a structure-Activity relationship study. Biochem Pharmacol 76, 495-506
33. Ruiz PA & Haller D (2006) Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kB, IRF, and Akt signaling pathways in murine intestinal epithelial cells. J Nutr 136, 664-671
34. Walle T (2004) Absorption and metabolism of flavonoids. Free Radic Biol Med 36, 829-837
35. Manach C & Donovan JL (2004) Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 38, 771-785
36. Williamson G & Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81, 243S-255S.
37. Manach C, Williamson G, Morand C, et al. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S-242S.
38. Crespo ME, Galvez J, Cruz T, et al. (1999) Anti-inflammatory activity of diosmin and hesperidin in rat colitis induced by TNBS. Planta Med 65, 651-653
39. Ocete MA, Galvez J, Crespo ME, et al. (1998) Effects of morin on an experimental model of acute colitis in rats. Pharmacology 57, 261-270
40. Koboziev I, Karlsson F, Zhang S, et al. (2011) Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies. Inflamm Bowel Dis 17, 1229-1245
41. Reynolds JM, Martinez GJ, Nallaparaju KC, et al. (2012) Cutting edge: regulation of intestinal inflammation and barrier function by IL-17C. J Immunol 189, 4226-4230
42. Egesten A, Eliasson M, Olin AI, et al. (2007) The proinflammatory CXC-chemokines GRO-Alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids. Int J Colorectal Dis 22, 1421-1427
43. Allgayer H, Deschryver K & Stenson WF (1989) Treatment with 16, 160-dimethyl prostaglandin E2 before and after induction of colitis with trinitrobenzenesulfonic acid in rats decreases inflammation. Gastroenterology 96, 1290-1300
44. Martinez-Augustin O, Merlos M, Zarzuelo A, et al. (2008) Disturbances in metabolic, transport and structural genes in experimental colonic inflammation in the rat: a longitudinal genomic analysis. BMC Genomics 9, 490
45. Grisham MB, Volkmer C, Tso P, et al. (1991) Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 101, 540-547